Frederick Sancilio

Chief Executive Officer at Cynaptec Pharmaceuticals.

Raised on Cynaptec Pharmaceuticals filings

$6M

of $26M offered across 1 Form D filing

Company

Biotech · Stuart, FL

Stable oral psilocin drug for psychiatric disorders

Stable oral psilocin drug for psychiatric disorders

Cynaptec Pharmaceuticals Form D filings
Filed	Security	Sold of offered	Filing
Apr 17, 2025	Equity	$6M/ $26M	Form D

Also named on Cynaptec Pharmaceuticals filings